Costs need to be analyzed for an effective provision of healthcare services. In our country, there are insufficient number of studies on cost analysis of the treatment of Status Epilepticus (SE). In this study, we aimed to investigate the treatment costs of patients admitted to intensive care units due to SE and contribute to the relevant data in our country. We conducted a retrospective review of patients who were admitted to the intensive care unit with a definitive diagnosis of SE between August 2018 and August 2019. We evaluated the demographic data, duration of hospitalization in the intensive care unit, the type of SE, the treatments given before and during hospitalization, inpatient medications and total costs and mortality rates in patients with SE. The mean age of 16 patients with SE was 41.1 ± 26.0 years, with a female/male ratio of 7/9. The patients were divided into three groups: 8 patients with primary generalized convulsive SE, 6 patients with focal onset generalized convulsive SE and 2 patients with non-convulsive SE. The average number of days of hospitalization in the intensive care unit was 7.44. Two of the patients died during the follow-up period. The average cost of medicines was 1344.25 TL (224.60 USD) and the total treatment cost was 4197.02 TL (701.25 USD). Analysis of costs in the field of healthcare provides sustainable and predictable health expenditures. A linear relationship has been shown between the number of days of hospitalization in the intensive care unit and the costs of medicines. An advanced age and acute symptomatic seizures are the leading causes of increase in the number of days of hospitalization. Multicenter studies with a higher number of participants are needed for a more accurate understanding of this data in our country
___
1. Atındağ EA, Baykan B. Status epileptikus. Türkiye Klinikleri. J Int Med Sci. 2006;2:85-91.
2. Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20:476-83.
3. Frost F, Hurley J, Petersen H, et al. A comparisonof two methods for estimating the health care costs of epilepsy. Clin Res. 2000;1020-6.
4. Penberthy LT, Towne A, Garnett LK, et al. Estimating the economic burden of status epilepticus to the health care system. Seizure. 2005;14:46-51.
5. Kutlu G, Biçer Gömceli Y, Sanivar F, et al. The cost of epilepsy in Ankara. Capital Turkey Epilepsi. 2010;16:147–52.
6. Keskin Güler S, Sağlam R, Yoldaş T, ve ark. Türkiye’de Status Epileptikus Hastalarında Yataklı Tedavi Maliyeti. Epilepsi. 2019;25:8-12.
7. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-23.
8. Ağırbaş İ (2016), HastaneYönetimiveOrganizasyonu, Siyasal Kitabevi, Ankara.
9. 9.Türkiye Istatistik Kurumu Sağlık Harcamaları İstatistikleri. http://www.tuik. gov.tr/PreTablo.do?alt_id=1084 Access date 16.07.2020.
10. Penberthy LT, Towne A, Garnett LK, et al. Estimating the economic burden of status epilepticus to the health care system. Seizure. 2005;14:46-51.
11. Kortland LM, Knake S, Rosenow F, et al. Cost of status epilepticus: A systematic review. Seizure. 2015;24:17-20.
12. Strzelczyk A, Ansorge S, Hapfelmeier J, et al. Length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany. Epilepsia. 2017;58:1533-41.
13. Zhou B, Huang Y, Wang J, et al. The aetiology of convulsive status epilepticus: a study of 258 cases in Western China. Seizure. 2014;23:717-21.
14. Tiamkao S, Pranboon S, Thepsuthammarat K, et al. Incidences and outcomes of status epilepticus: A 9-year longitudinal national study. Epilepsy Behav. 2015;49:135-7.
15. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800-10.
16. Liberalesso PB, Garzon E, Yacubian EM, et al. Higher mortality rate is associated with advanced age and periodic lateralized epileptiform discharges in patients with refractory status epilepticus. Arq Neuropsiquiatr. 2013;71:153-8.